Anti-MR monoclonal antibody

Pre-made anti-MR monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MR/NR3C2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T72168-Ab-1/ GM-Tg-hg-T72168-Ab-2Anti-Human MR/NR3C2 monoclonal antibodyHuman
GM-Tg-rg-T72168-Ab-1/ GM-Tg-rg-T72168-Ab-2Anti-Rat MR/NR3C2 monoclonal antibodyRat
GM-Tg-mg-T72168-Ab-1/ GM-Tg-mg-T72168-Ab-2Anti-Mouse MR/NR3C2 monoclonal antibodyMouse
GM-Tg-cynog-T72168-Ab-1/ GM-Tg-cynog-T72168-Ab-2Anti-Cynomolgus/ Rhesus macaque MR/NR3C2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T72168-Ab-1/ GM-Tg-felg-T72168-Ab-2Anti-Feline MR/NR3C2 monoclonal antibodyFeline
GM-Tg-cang-T72168-Ab-1/ GM-Tg-cang-T72168-Ab-2Anti-Canine MR/NR3C2 monoclonal antibodyCanine
GM-Tg-bovg-T72168-Ab-1/ GM-Tg-bovg-T72168-Ab-2Anti-Bovine MR/NR3C2 monoclonal antibodyBovine
GM-Tg-equg-T72168-Ab-1/ GM-Tg-equg-T72168-Ab-2Anti-Equine MR/NR3C2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T72168-Ab-1/ GM-Tg-hg-T72168-Ab-2; GM-Tg-rg-T72168-Ab-1/ GM-Tg-rg-T72168-Ab-2;
GM-Tg-mg-T72168-Ab-1/ GM-Tg-mg-T72168-Ab-2; GM-Tg-cynog-T72168-Ab-1/ GM-Tg-cynog-T72168-Ab-2;
GM-Tg-felg-T72168-Ab-1/ GM-Tg-felg-T72168-Ab-2; GM-Tg-cang-T72168-Ab-1/ GM-Tg-cang-T72168-Ab-2;
GM-Tg-bovg-T72168-Ab-1/ GM-Tg-bovg-T72168-Ab-2; GM-Tg-equg-T72168-Ab-1/ GM-Tg-equg-T72168-Ab-2
Products NameAnti-MR/NR3C2 monoclonal antibody
Formatmab
Target NameMR
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MR monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T72168-Ag-1Recombinant multi-species MCR/ MR/ NR3C2 protein
    ORF Viral VectorpGMLPm004119mouse Nr3c2 Lentivirus plasmid
    ORF Viral VectorvGMLPm004119mouse Nr3c2 Lentivirus particle


    Target information

    Target IDGM-T72168
    Target NameMR
    Gene ID4306,110784,25672,704789,475461,101081977,537614,100062570
    Gene Symbol and SynonymsMCR,MLR,MR,NR3C2,NR3C2VIT
    Uniprot AccessionP08235,P22199
    Uniprot Entry NameMCR_HUMAN,MCR_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000151623
    Target ClassificationNuclear Receptors, Tumor-associated antigen (TAA)

    The target: MR, gene name: NR3C2, also named as MCR, MLR, MRVIT, NR3C2. This gene encodes the mineralocorticoid receptor, which mediates aldosterone actions on salt and water balance within restricted target cells. The protein functions as a ligand-dependent transcription factor that binds to mineralocorticoid response elements in order to transactivate target genes. Mutations in this gene cause autosomal dominant pseudohypoaldosteronism type I, a disorder characterized by urinary salt wasting. Defects in this gene are also associated with early onset hypertension with severe exacerbation in pregnancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.